![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Laboratoires Besins International Paris Fr, based in Thailand, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Progesterone, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1998-108 - Rev 04
This Chemical Type CEP, issued on February 09, 2015, remains in force until March 20, 2019, ensuring its reliability within the pharmaceutical industry.
Substance Number 429 associated with this CEP further emphasizes